Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

VitaSpring Biomedical Co. Ltd.

VSBCOTCEQUITYCurrent

Quarterly Report

Filed Apr 22, 2026Accepted Apr 22, 2026, 12:08 PM EDTCIK 1697884Accession 0001640334-26-000788
Share

Company context

Current securities

Recent company filings

  1. 10-Q filingSep 17, 2026
  2. NT 10-Q filingSep 15, 2026
  3. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 10, 2026
  4. 10-K filingJun 17, 2026
  5. 10-Q filingJun 17, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗